Listing Application Approved News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Listing Application Approved. Real-time updates on events, politics, business and more.

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

April 3, 2024

Companys Listing Application Approved by Nasdaq VICTORIA, BC, April 3, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ; , a clinical-stage biotechnology company leveraging its proprietary...

Eupraxia Pharmaceuticals Inc Toronto Stock Exchange Company Listing Application Listing Application Approved Eupraxia Pharmaceuticals Nasdaq Capital Market

Source: marketscreener.com

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

April 3, 2024

/PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its...

Toronto Stock Exchange Company Listing Application Eupraxia Pharmaceuticals Inc Listing Application Approved Eupraxia Pharmaceuticals Nasdaq Capital Market

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Listing Application Approved News Today

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

Explore More Categories